Test Tren Bold Blend 400mg

Active ingredients: Testosterone Enanthate, Boldenone Undecylenate, Trenbolone Enanthate
Carrier Oil: Ethyl Oleate (EO)
Pharmacological category: Anabolic steroid
Active life: 8 days
Detection time: 5 months

72.1$

Description

Test Tren Bold blend 400 mg

Active ingredients

Testosterone Enanthate, Boldenone Undecylenate, Trenbolone Enanthate

Mechanism of action

The blend combines three long‑acting anabolic steroids, each acting as a potent androgen receptor (AR) agonist. Testosterone Enanthate provides a baseline androgenic effect and can be aromatized to estradiol, while Boldenone Undecylenate (Boldenone) binds AR with high affinity and modestly aromatizes, supporting red blood cell production. Trenbolone Enanthate binds AR with very high affinity, does not aromatize, and strongly inhibits 5‑alpha‑reductase, leading to pronounced anabolic effects without estrogen‑related side effects.

Indications (off‑label)

Males: Used by bodybuilders and athletes to increase lean muscle mass, strength, and nitrogen retention while minimizing water retention. Also employed in post‑cycle therapy (PCT) to restore endogenous testosterone production after a cycle of shorter‑acting steroids.
Females: Rarely used due to high androgenic potency; may be considered in specific medical contexts (e.g., severe muscle wasting) under strict supervision.

Contraindications

  • Known hypersensitivity to any component of the blend.
  • Uncontrolled hypertension or cardiovascular disease.
  • Active prostate or breast cancer.
  • Pregnancy or lactation (risk of fetal virilization).

Side effects

  • Common: acne, oily skin, increased body hair, mood swings, insomnia, and elevated blood pressure.
  • Serious (dose‑dependent): hepatotoxicity, lipid profile disturbances (↓ HDL, ↑ LDL), potential cardiomyopathy, and suppression of the hypothalamic‑pituitary‑gonadal axis.

Drug interactions

  • CYP3A4 inhibitors (ketoconazole, erythromycin) may increase plasma levels of all three esters.
  • Anticoagulants (warfarin) can have additive effects on bleeding risk.
  • Antihypertensives may require dose adjustment due to steroid‑induced hypertension.

Dosage

Typical protocol for experienced users: 400 mg total blend administered intramuscularly once every 10‑14 days. The blend is often split into two equal injections (200 mg each) to improve absorption and reduce injection‑site discomfort. Beginners should start with a lower total dose (e.g., 200 mg weekly) and monitor side‑effects closely.

Storage

Store at controlled room temperature (15‑30 °C) in a dark, dry place. Protect from moisture and direct sunlight. Keep out of reach of children.

Regulatory compliance statements

The product is manufactured under Good Manufacturing Practices (GMP) and complies with applicable regulatory standards for pharmaceutical‑grade anabolic steroids.

Safety information

Overdose instructions: Seek immediate medical attention; monitor cardiovascular status and liver function.
Adverse reactions: Report any severe or unexpected reactions (e.g., chest pain, severe mood changes) to a healthcare professional promptly.

Beligas Pharmaceuticals

Beligas Pharmaceuticals - AASDEPOT
Beligas Pharmaceuticals, a prominent name in the pharmaceutical and biotechnology industry. With headquarters in Belgium and manufacturing sites in Belgium and Shanghai, China, Beligas Pharmaceuticals specializes in developing and producing pharmacological substances that enhance the quality of life.
We are authorized distributors!

Why choose AASDEPOT? 🔥

1000+ satisfied customers ✅
Best deals on the market
Lab‑tested products from top manufacturers
24/7 customer support
Fast worldwide delivery 🌍
Top‑reviewed by customers (2025) 🏆

You may also like…